Benkel M, Brasch F, Neumann J D, Altendorf-Hofmann A, Sendt W
Krankenhaus St. Joseph Stift, Klinik für Allgemein- und Viszeralchirurgie, Bremen, Deutschland.
Zentralbl Chir. 2012 Feb;137(1):71-2. doi: 10.1055/s-0030-1262764. Epub 2011 Mar 1.
Neuroendocrine tumours of the gastroenteropancreatic system (GEP-NETs) are rare, in particular those of the gallbladder. Due to the limited therapeutic options, surgical resection is favoured.
Described below is the case of a 69-year-old male with a lymphogenically metastasising, poorly differentiated neuroendocrine carcinoma of the gallbladder who presented with unspecific abdominal pain.
Following complete surgical resection of the tumour and the lymph node metastases he developed a recurrence 6 weeks post-operatively. The recurrence was treated with chemotherapy. Re-staging after three courses, however, showed further tumour progression. Prior to the start of a second-line treatment the patient died 13 weeks after surgery.
This case demonstrates the complexity of this rare disease with diagnosis in advanced tumour stage and poor prognosis.
胃肠胰系统神经内分泌肿瘤(GEP-NETs)较为罕见,尤其是胆囊神经内分泌肿瘤。由于治疗选择有限,手术切除是首选方法。
下文描述的是一名69岁男性患者,患有经淋巴转移的低分化胆囊神经内分泌癌,表现为非特异性腹痛。
肿瘤及淋巴结转移灶完全切除术后6周出现复发。复发后接受化疗。然而,三个疗程后的再次分期显示肿瘤进一步进展。在二线治疗开始前,患者术后13周死亡。
本病例显示了这种罕见疾病在晚期肿瘤阶段诊断及预后不良的复杂性。